KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Clorox (CLX) over the last 16 years, with Q4 2025 value amounting to $2.0 billion.

  • Clorox's Accounts Payables rose 3404.11% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year increase of 3404.11%. This contributed to the annual value of $1.8 billion for FY2025, which is 2301.48% up from last year.
  • According to the latest figures from Q4 2025, Clorox's Accounts Payables is $2.0 billion, which was up 3404.11% from $1.9 billion recorded in Q3 2025.
  • In the past 5 years, Clorox's Accounts Payables registered a high of $2.0 billion during Q1 2025, and its lowest value of $1.4 billion during Q1 2021.
  • In the last 5 years, Clorox's Accounts Payables had a median value of $1.6 billion in 2022 and averaged $1.6 billion.
  • In the last 5 years, Clorox's Accounts Payables tumbled by 1229.85% in 2022 and then skyrocketed by 3404.11% in 2025.
  • Over the past 5 years, Clorox's Accounts Payables (Quarter) stood at $1.5 billion in 2021, then rose by 3.18% to $1.6 billion in 2022, then rose by 3.78% to $1.6 billion in 2023, then fell by 11.46% to $1.5 billion in 2024, then soared by 34.04% to $2.0 billion in 2025.
  • Its Accounts Payables stands at $2.0 billion for Q4 2025, versus $1.9 billion for Q3 2025 and $1.8 billion for Q2 2025.